Navigation Links
Weekly yoga class yields similar lower back pain relief as 2 classes
Date:7/2/2013

(Boston) Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that a weekly yoga class provided similar lower back pain relief and reduced the need for pain medication as twice weekly classes in lower income minority patients. The results of the study indicate that patients interested in trying yoga for lower back pain could benefit from attending a medically appropriate weekly yoga class.

The study, published in Evidence-Based Complementary and Alternative Medicine, was led by first author Robert Saper, MD, MPH, associate professor of family medicine at BUSM and director of integrative medicine at BMC.

While previous studies have shown that yoga can be an effective treatment for chronic lower back pain, few studies have studied this among specific populations.

"Lower income patients often have worse lower back pain due to limited access to both mainstream health care treatments and complementary treatments such as yoga, massage and acupuncture," said Saper.

In this 12-week randomized trial, 95 predominantly low-income adults suffering from moderate to severe lower back pain were divided into two groups. One group attended yoga class once a week and the other attended twice a week, and both groups were encouraged to practice the poses and techniques at home. At the end of the 12 weeks, both groups of participants experienced similar and substantial decreases in their pain level and need for pain medications, but there was no additional benefit seen in those attending twice a week. Also, their ability to perform daily functions improved.

"Given the similar improvement seen in once weekly yoga classes, and that once a week is more convenient and less expensive, we recommend patients suffering from lower back pain who want to pursue yoga attend a weekly therapeutic yoga class," said Saper.


'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
2. Desert to Rainforest global classroom links future teachers, classrooms in Phoenix and Panama
3. Weeding out invasive species with classical biological control
4. KIT researchers succeed in realizing a new material class
5. Large, medically important class of proteins starts to yield its secrets
6. Powerful class of antioxidants may be potent Parkinsons treatment
7. Crop Science Society of America presents 2012 class of fellows
8. DNA analysis aids in classifying single-celled algae
9. A class of RNA molecules protects germ cells from damage, Penn vet researchers show
10. 34 ASPB members elected to 2012 class of AAAS Fellows
11. Study confirms prognostic value of new IASLC/ATS/ERS adenocarcinoma sub-classification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology: